Melanoma Cancer Immunotherapy Using PD-L1 siRNA and Imatinib Promotes Cancer-Immunity Cycle
Crossref DOI link: https://doi.org/10.1007/s11095-020-02838-4
Published Online: 2020-05-31
Published Print: 2020-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Chenyang
Han, Xiuping
Funding for this research was provided by:
Shengjing Hospital of China Medical University, Shenyang (-)
Text and Data Mining valid from 2020-05-31
Version of Record valid from 2020-05-31
Article History
Received: 26 February 2020
Accepted: 30 April 2020
First Online: 31 May 2020